The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Understanding 12.5mg Mounjaro in the UK
The 12.5mg dose is an escalation step in Mounjaro (tirzepatide) treatment, typically reached after 16–20 weeks of dose titration. This comprehensive UK guide explains NHS eligibility criteria, how the 12.5mg dose fits into your treatment journey, and what clinical evidence shows about weight loss at this level. Whether you're considering this medication or already in treatment, understanding the progression and context helps you make informed health decisions with your prescriber.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
NHS Eligibility & the 12.5mg Dose in UK Treatment Pathways
Mounjaro at 12.5mg is prescribed in the UK through two main routes: NHS specialist weight management services (tier 3) and private prescribing via GPhC-registered online pharmacies. NHS eligibility requires a BMI of 30 kg/m² or above, or 27–29.9 kg/m² with at least one weight-related health condition such as type 2 diabetes, hypertension, or cardiovascular disease. Adults of South Asian, Chinese, Black African, or Black Caribbean heritage may qualify at lower BMI thresholds (from 27.5 kg/m²) due to higher metabolic risk at these levels.
The SURMOUNT-1 clinical trial showed that participants on the 15mg maximum dose (the highest available) achieved average weight loss of approximately 20.9% of body weight over 72 weeks when combined with lifestyle changes. The 12.5mg dose sits within the escalation pathway toward this maximum, typically prescribed weeks 17–20. Individual results vary significantly based on metabolism, adherence, and concurrent lifestyle modifications.
- MHRA approval: Mounjaro is approved with additional monitoring (Black Triangle ▼ status)
- Prescription-only: Requires clinical assessment by a licensed prescriber
- Weekly dosing: Each dose is a single 12.5mg injection administered once per week
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS vs Private Access: Getting Mounjaro at 12.5mg in the UK
NHS access is through referral to tier 3 specialist weight management services, typically initiated by your GP. Availability varies significantly by region—some areas have substantial waiting lists of several months to over a year. Private access is available via online consultations with UK-licensed prescribers, who assess your eligibility and issue prescriptions dispensed by GPhC-registered pharmacies. Private treatment removes NHS waiting lists but involves direct costs, typically £200–£280 per month depending on dose and provider.
Both routes require the same clinical assessment criteria: proof of eligible BMI, confirmation of any weight-related health conditions, and assessment of contraindications (such as pregnancy, allergy, or severe gastroparesis). Use our free GLP-1 weight loss calculator to estimate potential outcomes, and the BMI calculator to confirm your current BMI category against NHS thresholds. Your GP or prescriber will provide personalised guidance on which route suits your circumstances.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
How long does it take to reach the 12.5mg Mounjaro dose?
Mounjaro follows a structured dose escalation schedule. Starting at 2.5mg (weeks 1–4), the dose increases by 2.5mg every four weeks if tolerated: 5mg (weeks 5–8), 7.5mg (weeks 9–12), 10mg (weeks 13–16), 12.5mg (weeks 17–20). Most people reach 12.5mg around week 17–20 of treatment, though the schedule can be adjusted by your prescriber based on side effects or individual tolerance.
Is 12.5mg Mounjaro available on the NHS in the UK?
Yes, Mounjaro is approved for NHS use through NICE guidance for specialist tier 3 weight management services. However, NHS access depends on your regional integrated care board (ICB) capacity and current waiting lists. Many areas have significant delays. Private access is available without NHS waiting lists through licensed prescribers if you meet eligibility criteria.
What weight loss can I expect on 12.5mg Mounjaro?
Clinical trial data shows average weight loss of approximately 15–21% of body weight at maximum doses (up to 15mg) over 72 weeks, achieved alongside reduced-calorie diet and increased activity. Results at 12.5mg vary individually. Factors affecting outcomes include starting weight, metabolism, consistency of the reduced-calorie intake, physical activity level, and genetic factors. Your prescriber can discuss realistic expectations for your situation.
Can I stay on 12.5mg Mounjaro or do I need to increase further?
Some people remain on 12.5mg as their maintenance dose if they achieve good tolerability and satisfactory weight loss. Others escalate to the maximum 15mg dose for additional benefit. Your prescriber will decide the optimal dose based on your response, side effects, and weight loss goals. Dose adjustments are always your prescriber's decision.
What are the main side effects at 12.5mg Mounjaro?
Common side effects include nausea, diarrhoea, constipation, vomiting, and abdominal pain—typically mild to moderate and often improving over time. Less common effects are indigestion, headache, fatigue, and injection site reactions. Serious side effects are rare but can include severe abdominal pain (possible pancreatitis) or gallbladder problems. Report any concerning symptoms to your prescriber immediately.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.